期刊文献+

5-HT_3受体阻滞剂帕洛诺司琼 被引量:16

5-HT_3 receptor antagonists:palonosetron
下载PDF
导出
摘要 帕洛诺司琼(palonosetron)是新型5-HT_3受体阻滞剂,适用于中~重度呕吐化疗所引起的恶心、呕吐,其与传统5-HT_3受体阻滞剂相比,具有疗效高、作用时间长、用量小、不良反应少的优点。现对帕洛诺司琼的作用机制、药动学、安全性以及临床应用等做一简单综述。 Palonosetron (Aloxi) belongs to a relatively new, but well-known, class of anti-emetics, the 5-HT3 receptor antagonists. It is indicated for the prevention of acute or delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy. Compared with traditional 5-HT3 receptor antagonists, palonosetron shows several advantages, such as more potent efficacy, extended action time, low dosage and fewer side effects. This paper reviews the mechanism, pharmacokinetics, clinical application and safety of palonosetron.
出处 《中国新药杂志》 CAS CSCD 北大核心 2006年第10期833-835,共3页 Chinese Journal of New Drugs
关键词 帕洛诺司琼 5-HT3受体阻滞剂 化疗 恶心 呕吐 palonosetron 5-HT3 receptor antagonist chemotherapy nausea vomiting
  • 相关文献

参考文献8

  • 1林清强,叶锦林.新型5-HT3受体拮抗剂帕洛诺司琼[J].中国科技信息,2005(11):157-157. 被引量:12
  • 2Helsinn Healthcare SA.AloxiTM (palonosetron hydrochloride) Injection NDA no.021-372 [ EB/OL].[ 2004-04-15 ].http://www.fda.gov/cder.
  • 3GRALLA R,LICHINITSER M,VAN DER VEGT S,et al.Palonasetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy:results of a double-blind randomized phase Ⅲ trail comparing single dosed of palonosetron with ondansetron [ J ].Ann Oncol,2003,14 (10):1570-1577.
  • 4STOLTZ R,CYONG JC,SHAH A,et al.Pharmacokinetic and safety evaluation of palonosetron,a 5-hydroxytryptamine-3 receptor antagonist,in U.S.and Japanese healthy subjects [ J].J Clin Pharm,2004,44 (5):520-531.
  • 5STOLTZ R,PARISI S,SHAH A,et al.Pharmacokinetics,metabolism and excretion of intravenous [ 14C ]-palonosetron in healthy human volunteers [ J].Biopharm Drug Dispos,2004,25(8):329-337.
  • 6NAVARI RM.Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting-two new agents[ J].J Support Oncol,2003,1 (2):89-103.
  • 7EISENBERG P,FIGUEROA-VADILLO J,ZAMORA R,et al.Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron,a pharmacologically novel 5-HT3 receptor antagonist:results of a phase Ⅲ,single-dose trial versus dolasetron [ J ].Cancer,2003,98 (11):2473-2482.
  • 8SIDDIQUI MA,SCOTT LJ.Palonosetron [ J ].Drugs,2004,64(10):1125-1132;discussion 1133-1134.

二级参考文献1

共引文献11

同被引文献91

引证文献16

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部